| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.0M | +2.6% | +10.2% |
| Cost of Revenue | $736K | +4.6% | -13.9% |
| Gross Profit | $3.3M | +2.2% | +17.6% |
| R&D Expense | $624K | +3.4% | +13.1% |
| SG&A Expense | $2.2M | -5.1% | -8.2% |
| Operating Income | $441K | +61.0% | +360.9% |
| Interest Expense | $364K | — | -57.2% |
| Pre-tax Income | -$717K | -3.8% | +41.7% |
| Net Income | -$717K | -3.8% | +41.7% |
| EPS (Basic) | -$0.04 | -44.8% | +22.2% |
| EPS (Diluted) | -$0.04 | -44.8% | +22.2% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $256K | -16.9% | -49.7% |
| Accounts Receivable | $1.6M | -24.8% | +27.7% |
| Inventory | $2.0M | -12.5% | +25.8% |
| Current Assets | $5.0M | -10.0% | +2.5% |
| Total Assets | $5.7M | -10.1% | -5.0% |
| Current Liabilities | $23.8M | +0.8% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$698K | — | — |
| Financing Cash Flow | $649K | — | — |
| +12.6% |
| Total Liabilities | $38.2M | +0.6% | +6.8% |
| Stockholders' Equity | -$34.2M | -2.5% | -7.2% |